Evidence map›Paper›PMID 23431375›Full record

ArticlePloS one2013

A cross-sectional study to assess HPV knowledge and HPV vaccine acceptability in Mali.

Danielle N Poole, J Kathleen Tracy, Lauren Levitz, Mali Rochas, Kotou Sangare, Shahla Yekta, Karamoko Tounkara, Ben Aboubacar, Ousmane Koita, Mark Lurie and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 4 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 4 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Malignancy and viral infections in Sub-Saharan Africa: A review.Frontiers in virology (Lausanne, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Danielle N PoolePublic Health Program, Brown University, Providence, Rhode Island, United States of America. danielle.n.poole@gmail.com
J Kathleen Tracy
Lauren Levitz
Mali Rochas
Kotou Sangare
Shahla Yekta
Karamoko Tounkara
Ben Aboubacar
Ousmane Koita
Mark Lurie
Anne S De Groot
GAIA Vaccine Foundation · USBrown University · USUniversity of Bamako · MLProvidence College · USUniversity of Maryland, Baltimore · US

Funding

Spatial Analysis CoreR24HD041020 · NICHD · BROWN UNIVERSITY · PI FOSTER, ANDREW D. · 2001 to 2016
$7.4M
NICHD NIH HHS R24 HD041020
6 · The paper itself

Abstract

Despite a high prevalence of oncogenic human papilloma virus (HPV) infection and cervical cancer mortality, HPV vaccination is not currently available in Mali. Knowledge of HPV and cervical cancer in Mali, and thereby vaccine readiness, may be limited. Research staff visited homes in a radial pattern from a central location to recruit adolescent females and males aged 12-17 years and men and women aged ≥ 18 years (N = 51) in a peri-urban village of Bamako, Mali. Participants took part in structured interviews assessing knowledge, attitudes, and practices related to HPV, cervical cancer, and HPV vaccination. We found low levels of HPV and cervical cancer knowledge. While only 2.0% of respondents knew that HPV is a sexually transmitted infection (STI), 100% said they would be willing to receive HPV vaccination and would like the HPV vaccine to be available in Mali. Moreover, 74.5% said they would vaccinate their child(ren) against HPV. Men were found to have significantly greater autonomy in the decision to vaccinate themselves than women and adolescents (p = 0.005), a potential barrier to be addressed by immunization campaigns. HPV vaccination would be highly acceptable if the vaccine became widely available in Bamako, Mali. This study demonstrates the need for a significant investment in health education if truly informed consent is to be obtained for HPV vaccination. Potential HPV vaccination campaigns should provide more information about HPV and the vaccine. Barriers to vaccination, including the significantly lower ability of the majority of the target population to autonomously decide to get vaccinated, must also be addressed in future HPV vaccine campaigns.

Indexed as

Health Knowledge, Attitudes, PracticeAdolescentAdultChildCross-Sectional StudiesDecision MakingFemaleHumansMaleMaliPapillomavirus InfectionsPapillomavirus VaccinesPatient ParticipationSexually Transmitted Diseases, ViralUrban PopulationUterine Cervical NeoplasmsPapillomavirus Vaccines

Identifiers

PMID23431375
PMCPMC3576405
OpenAlexW1985364672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.